Title:
新規テトラゾロン誘導体
Document Type and Number:
Japanese Patent JP2016521736
Kind Code:
A
Abstract:
本発明は、式（Ｉ）（式中、Ｒ１及びＲ２は、本明細書及び特許請求の範囲のように定義される）の化合物に関する。式（Ｉ）の化合物は、医薬として使用され得る。
Inventors:
Greetter, uwe
Nettecofen, Matthias
Puermann, Bernd
Laver, Stephan
Rogers-Evans, Mark
Schultz-Ghersh, Tanya
Nettecofen, Matthias
Puermann, Bernd
Laver, Stephan
Rogers-Evans, Mark
Schultz-Ghersh, Tanya
Application Number:
JP2016518919A
Publication Date:
July 25, 2016
Filing Date:
June 04, 2014
Export Citation:
Assignee:
F. HOFFMANN-LA ROCHE AKTIENGESELLSCHAFT
International Classes:
C07D257/04; A61K31/41; A61K31/4155; A61K31/4196; A61K31/42; A61K31/4245; A61K31/438; A61K31/4439; A61K31/454; A61K31/4725; A61K31/496; A61K31/497; A61K31/5377; A61K31/541; A61P1/02; A61P1/04; A61P1/16; A61P3/10; A61P9/00; A61P9/10; A61P11/00; A61P13/12; A61P17/02; A61P19/08; A61P21/02; A61P25/00; A61P25/04; A61P25/16; A61P25/28; A61P27/02; A61P27/06; A61P29/00; A61P29/02; A61P37/06; C07D401/04; C07D401/06; C07D401/12; C07D403/06; C07D403/12; C07D403/14; C07D413/06; C07D413/14; C07D491/107
Domestic Patent References:
| JP2013521291A | 2013-06-10 |
Foreign References:
| WO2009117444A1 | 2009-09-24 |
Other References:
KANG,S.K. ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. Vol.18, JPN6018017139, 2008, pages 2385 - 2389
Attorney, Agent or Firm:
Patent business corporation Tsukuni